Analysts have clear opinions on TNDM.

There are 6 analysts on the Wall offering 12 month price targets for Tandem Diabetes Care in the last 3 months. The average price target is $79.50 with a high forecast of $100.00 and a low forecast of $68.00. The average price target represents a 17.40% increase from the last price of $67.72.
Tandem Diabetes Care, Inc. (TNDM) is followed by 6 analysts on the street.

Alexander Nowak from Craig-Hallum rates it a Buy with a target of $92.00.

Similarly, 2 months ago Danielle Antalffy of Leerink Partners Reiterated a Hold with a target of $68.00.

The consensus on the street is Strong Buy.

What does Tandem Diabetes Care, Inc.(TNDM) do ?
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Tandem Diabetes Care, Inc. (TNDM) Insider Trades

Multiple company employees have indulged in significant insider trading. Tandem Diabetes Care, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):

Exec COB, Blickenstaff Kim D : S – Sale(-$11,970,491) of TNDM in the trading session of 2019-12-16.

EVP, CFO Vosseller Leigh : S – Sale+OE(-$703,500) of TNDM in the trading session of 2019-11-25.

Pres, CEO Sheridan John F : S – Sale+OE(-$32,340) of Tandem Diabetes Care, Inc. in the trading session of 2019-11-25.

Looking for stocks just like TNDM?

Based on Wall Street analyst research, several stocks are similar to TNDM
They are:
– PODD [Info can be found here: ]
– DXCM [Info can be found here: ]
– JNJ [Info can be found here: ]